Notification

×

Source: Agency

Baby-only COVID-19 Vaccine Launched in United States

| 21.6.22 |
    Share

Baby-only COVID-19 Vaccine Launched in United States

 The United States Agency for Disease Control and Prevention (CDC) on Saturday (18/6) recommended the use of the vaccine for children aged over six months and the CDC allowed the vaccine to be given starting next week. The permit was issued by the CDC after the agency's advisory panel voted on Saturday on recommendations for injecting a COVID-19 vaccine for children of this age group. "We know millions of people and nurses desperately want their children vaccinated, and with today's decision, it can be done," CDC Director Rochelle Walensky said in a statement.

 The US drug and regulatory agency (FDA) on Friday (June 17) issued a permit to use Moderna Inc's vaccine in children ages 6 months to 5 years. Permission was also granted for Pfizer-BioNTech-made vaccines in children aged 6 months to four years. The Pfizer vaccine has previously been approved for use in children over 5 years of age. "This infection is killing children and we have a chance to prevent it," said Beth Bell, one of the doctors on the advisory panel, after the vote. President Joe Biden's administration plans to roll out a vaccine for children under five next week. "Next week, parents will be able to schedule registration at locations such as pediatric clinics, children's hospitals, and pharmacies," Biden said in a statement on Saturday as reported by Reuters, quoted from Antara, Sunday (19/6/2022). ). 

While many parents in the United States desperately want their children to be vaccinated, it's not clear how many people are interested in vaccines. Pfizer-BioNTech's vaccine was licensed for use in children ages 5-11 in October last year, but only about 29 percent of children in that age group have so far been fully vaccinated, according to federal government data. Health officials have emphasized vaccinating children ahead of the new school year. They hope that vaccination in this age group can help prevent hospitalization rates and deaths from COVID-19 from rising again.
COVID-19 cases in the world are still fluctuating, although weekly death cases still show a stable trend and are not as severe as in the previous two years. 





However, the presence of the Omicron sub-variants, namely BA.4 and BA.5 carries a new risk of increasing cases. Based on data from Johns Hopkins University, Sunday (6/19/2022), there were a total of 538 million cases of COVID-19 recorded during the pandemic. Within 28 days, there were 13.8 million new cases, as well as 40,000 deaths.
Regarding the four-dose injection, the CDC in the United States has provided these recommendations for children aged 5-11 years who have immune problems. In fact, teens and adults are advised to get five doses. “People aged 12 years and older who are moderately or severely immunocompromised should receive a total of 5 doses of the COVID-19 mRNA vaccine according to current developments.

 The five doses include 3 doses of Pfizer-BioNTech or Moderna's COVID-19 vaccine, plus 2 Pfizer-BioNTech booksters or Moderna's COVID-19 vaccine," the CDC wrote on its website. People who have weak immune problems, for example, patients with cancer, people who have received organ transplants (thus taking drugs to suppress the immune system), received CAR T-cell cancer therapy or stem cell transplants for the past 2 years, people with immune deficiencies such as DiGeorge Syndrome or Wiskott-Aldrich Syndrome. Long-term HIV sufferers also fall into this category, as well as people taking high doses of corticosteroids or other drugs that suppress the immune response. The CDC also advises people in these categories to consult a doctor regarding COVID-19 vaccinations.


×
Latest news Update